Bill Text: US HB4597 | 2019-2020 | 116th Congress | Introduced

Bill Title: ACCESS for Biosimilars Act of 2019 Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019

Spectrum: Slight Partisan Bill (Democrat 2-1)

Status: (Introduced - Dead) 2019-10-02 - Referred to the Subcommittee on Health. [HB4597 Detail]

Download: US_Congress-2019-HB4597-Introduced.pdf
It appears your computer is unable to display this document, however you can download the file from the links above.

LegiScan Search

View Top 50 Searches

Select area of search.
Find an exact bill number.
Search bill text and data. [help]
Reset

LegiScan Trends

View Top 50 National

US SB51 A bill to provide for the admission of the State of Washington, D.C. into...
MS HB160 IHL; require board to conduct a review of tenured professors every five...
DE HCR2 Re-establishing The Public Education Funding Commission.
NY S02009 Provides a corrective remedy for certain administrative errors, omissions...
NH SB187 Adopting the dentist and dental hygienist compact.
WA HB1576 Concerning the designation of historic landmarks by cities.
NY A02703 Requires proof of installation, maintenance and regular use of ignition...
CT SB00269 An Act Requiring The State To Enter Reciprocity Agreements With Other States...
OH HB18 Enact the Ohio Strategic Cryptocurrency Reserve Act
IN HB1639 Stillbirths.
feedback